Recent studies show the surging popularity of Ozempic, Wegovy and similar drugs for weight loss is driving employer health ...

A 14-study meta-analysis found GLP-1 receptor agonists -- especially semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

As the use of GLP-1s, like Ozempic, has skyrocketed in the U.S., two researchers at UMass Chan Medical School in Worcester ...

“In general, we tend to see more weight loss with GLP-1-based medication treatment in patients who are female, those who do ...

Originally developed for diabetes, GLP-1 drugs like Ozempic are showing remarkable potential in combating addiction. Emerging ...

GLP-1 RAs, particularly semaglutide and tirzepatide, outperform older medications in achieving significant weight loss in adults with and without type 2 diabetes. Semaglutide and tirzepatide met ...

GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San ...

As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...

Company to offer the first clinically validated dietary management of sarcopenia, now available for GLP-1 muscle loss, positioning Wellgistics to help 6,500+ independent pharmacy network (‘Pharmacy ...

This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss ...

SAHPRA has confirmed that no oral GLP-1 solutions have been approved for use in the country. If you have been scrolling ...